Definitive Healthcare (DH) Cost of Revenue (2020 - 2026)

Definitive Healthcare (DH) has reported Cost of Revenue for 7 consecutive years, with $14.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue rose 3.66% year-over-year to $14.7 million; the trailing twelve-month figure through Jun 2026 stood at $57.6 million (down 0.53% YoY), and the FY2025 full-year result was $58.2 million, up 6.42% from the prior year.
• Cost of Revenue grew to $14.7 million in Q2 2026 per DH's latest filing, from $14.3 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $22.2 million in Q4 2023 and bottomed at $5.9 million in Q1 2022.
• Historically, Cost of Revenue has averaged $12.0 million across 5 years, with a median of $13.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Cost of Revenue surged 210.38% in 2023, then tumbled 33.81% in 2024.
• Over 5 years, Cost of Revenue stood at $7.1 million in 2022, then soared by 210.38% to $22.2 million in 2023, then sank by 33.81% to $14.7 million in 2024, then slipped by 0.42% to $14.6 million in 2025, then climbed by 0.2% to $14.7 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $14.7 million, $14.3 million, and $14.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.